Company research
ASLAN Pharmaceuticals Ltd
CIK 1722926Updated Nov 16, 2026
Securities
Historical securities (2)
APRTF · OTC · equity · closed Nov 11, 2019ASLN · NASDAQ · adr · closed Jul 18, 2024APRTF price & chart
Historical security
This listing closed Nov 11, 2019. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
No filing activity has been returned.
Financials
FY 2023 · USDSource
Source
Source
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossUSD | -44,219,604Source | -51,382,417Source | -31,590,582Source | -16,971,289Source |
| Cash flows from financing activities: | ||||
| Dividends paid | — | — | — | — |
| Additional Financial Items | ||||
| AdjustmentsForCurrentTaxOfPriorPeriodUSD | 19,416Source | 19,842Source | — | — |
| AdjustmentsForFinanceCostsUSD | 4,331,661Source | 3,675,689Source | 1,860,954Source | 1,247,331Source |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableUSD | -4,865,880Source | 9,667,699Source | 797,228Source | 447,715Source |
| AdjustmentsForSharebasedPaymentsUSD | — | — | 2,193,367Source | 345,836Source |
| AdjustmentsForUnrealisedForeignExchangeLossesGainsUSD | 198,842Source | 88,866Source | -230,619Source | 206,457Source |
| GeneralAndAdministrativeExpenseUSD | 13,240,218Source | 9,881,993Source | 11,825,131Source | 7,169,177Source |
| IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesUSD | 126,208Source | 105,000Source | — | — |
| InterestPaidClassifiedAsOperatingActivitiesUSD | 3,318,576Source | 2,338,715Source | — | 2,490Source |
| InterestReceivedClassifiedAsOperatingActivitiesUSD | 125,825Source | 1,312Source | 219Source | 592Source |
| OtherAdjustmentsToReconcileProfitLossUSD | — | 50,109Source | — | — |
| ProceedsFromBorrowingsClassifiedAsFinancingActivitiesUSD | — | 5,000,000Source | 20,000,000Source | — |
| ProceedsFromIssuingSharesUSD | 7,681,312Source | — | 101,555,708Source | 7,643,240Source |
| ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivitiesUSD | 148Source | 1,172Source | — | 1,214Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD | — | — | 12,360Source | — |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesUSD | 12,000,000Source | — | 7,784,087Source | — |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Additional Financial Items | ||||
| BasicEarningsLossPerShareUSD per share | -0.11Source | — | — | — |
| CurrentTaxExpenseIncomeUSD | 113,251Source | 79,379Source | — | — |
| DepreciationAndAmortisationExpenseUSD | 348,498Source | 331,752Source | 282,224Source | 297,758Source |
| DilutedEarningsLossPerShareUSD per share | -0.11Source | — | — | — |
| EmployeeBenefitsExpenseUSD | 12,741,212Source | 10,755,327Source | 9,391,395Source | 5,085,544Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD | 2,769,279Source | 132,200Source | 2,428,128Source | 132,200Source |
| ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsedUSD | — | — | — | 2,732Source |
| ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsedUSD | — | — | — | 107,940Source |
| FinanceCostsUSD | 4,331,661Source | 3,675,689Source | 1,860,954Source | 1,247,331Source |
| GainsLossesRecognisedWhenControlInSubsidiaryIsLostUSD | — | — | 2,307,735Source | — |
| GeneralAndAdministrativeExpenseUSD | 13,240,218Source | 9,881,993Source | 11,825,131Source | 7,169,177Source |
| GrossProfitUSD | 12,000,000Source | — | — | — |
| IncomeTaxExpenseContinuingOperationsUSD | 132,667Source | 99,221Source | — | 0Source |
| InterestExpenseUSD | 442,410Source | 431,052Source | 443,216Source | 431,143Source |
| InterestExpenseOnLeaseLiabilitiesUSD | 13,074Source | 12,544Source | 21,510Source | 40,425Source |
| OtherFinanceCostUSD | 4,878Source | 7,724Source | — | — |
| OtherIncomeUSD | 462,321Source | 386,138Source | 1,108,072Source | 888,046Source |
| PostemploymentBenefitExpenseDefinedBenefitPlansUSD | 415,509Source | 355,434Source | 257,128Source | 200,045Source |
| ProfitLossAttributableToNoncontrollingInterestsUSD | — | — | -268,964Source | -773,400Source |
| ProfitLossAttributableToOwnersOfParentUSD | -44,219,604Source | -51,382,417Source | -31,321,618Source | -16,197,889Source |
| ProfitLossBeforeTaxUSD | -44,086,937Source | -51,283,196Source | -31,590,582Source | -16,971,289Source |
| ProfitLossFromOperatingActivitiesUSD | -43,735,597Source | -47,882,487Source | -33,846,452Source | -16,483,297Source |
| ResearchAndDevelopmentExpenseUSD | 42,495,379Source | 38,000,494Source | 22,021,321Source | 9,314,120Source |
| RevenueFromInterestUSD | 404,981Source | 354,457Source | 219Source | 592Source |